|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash and due from financial institutions | |||||
| Due from Federal Reserve Bank and interest-bearing deposits in banks | |||||
| Securities available-for-sale, at fair value (amortized cost $174,278 and $369,155, net of allowance for credit losses of $0 and $0) | |||||
| Due from Federal Reserve Bank and interest-bearing deposits in other financial institutions | |||||
| Total cash and cash equivalents | |||||
| Debt securities available-for-sale, at fair value (amortized cost $234,947 and $218,488, net of allowance for credit losses of $0 and $0) | |||||
| Loans, net of allowance for credit losses on loans of $21,501 and $22,261 | |||||
| Federal Home Loan Bank stock, at cost | |||||
| Premises and equipment, net | |||||
| Cash surrender value of bank-owned life insurance policies | |||||
| Accrued interest receivable and other assets | |||||
| Total assets | |||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | |||||
| Non-interest-bearing deposits | |||||
| Interest-bearing | |||||
| Total deposits | |||||
| Short-term borrowings | |||||
| Subordinated debentures, net | |||||
| Accrued interest payable and other liabilities | |||||
| Total liabilities | |||||
| Preferred stock - no par value; 5,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | |||||
| Common stock - no par value; 25,000,000 shares authorized; 10,982,764 and 10,947,967 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | |||||
| Retained earnings | |||||
| Accumulated other comprehensive loss, net of taxes | |||||
| Total shareholders' equity | |||||
| Total liabilities and shareholders' equity |
Loading...
